Abstract

Functional brain network (FBN), estimated with functional magnetic resonance imaging (fMRI), has become a potentially useful way of diagnosing neurological disorders in their early stages by comparing the connectivity patterns between different brain regions across subjects. However, this depends, to a great extent, on the quality of the estimated FBNs, indicating that FBN estimation is a key step for the subsequent task of disorder identification. In the past decades, researchers have developed many methods to estimate FBNs, including Pearson’s correlation and (regularized) partial correlation, etc. Despite their widespread applications in current studies, most of the existing methods estimate FBNs only based on the dependency between the measured blood oxygen level dependent (BOLD) signals, which ignores spatial relationship of signals associated with different brain regions. Due to the space and material parsimony principle of our brain, we believe that the spatial distance between brain regions has an important influence on FBN topology. Therefore, in this paper, we assume that spatially neighboring brain regions tend to have stronger connections and/or share similar connections with others; based on this assumption, we propose two novel methods to estimate FBNs by incorporating the information of brain region distance into the estimation model. To validate the effectiveness of the proposed methods, we use the estimated FBNs to identify subjects with mild cognitive impairment (MCI) from normal controls (NCs). Experimental results show that the proposed methods are better than the baseline methods in the sense of MCI identification accuracy.

Highlights

  • Alzheimer’s disease (AD) is an age-related, progressive neurodegenerative disease with the main characteristics of memory loss and cognitive decline

  • We argue that the spatial distance between different brain regions may play a potentially important role in estimating functional brain network (FBN)

  • In order to verify the effectiveness of proposed methods, we conduct experiments based on the estimated FBNs

Read more

Summary

Introduction

Alzheimer’s disease (AD) is an age-related, progressive neurodegenerative disease with the main characteristics of memory loss and cognitive decline. Researchers have not yet found an effective way of treating AD completely. Brain networks with spatial constraints for MCI identification is currently believed to play an important role in preventing or delaying AD at the stage of mild cognitive impairment (MCI). To predict MCI (or AD as early as possible), researchers have explored many approaches from multiple aspects, including biochemistry [2], genetic [3], and brain imaging [4]. In recent years, functional magnetic resonance imaging (fMRI), which achieves blood oxygen level dependent (BOLD) signals, provides a noninvasive way of identifying subjects with MCI from normal controls (NCs). FMRI-based functional brain network (FBN) has become a potentially effective tool to find informative patterns in fMRI data, and has been used to investigate MCI identification. With the help of FBN analysis, researchers recently have made a considerable progress in probing the mechanism of neurological diseases [6]

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.